Edit

Ascension Ventures

http://www.ascensionventures.org
Last activity: 16.06.2026
Active
Invests in categories: CareHardwareHealthcareHealthTechManagementMedTechPlatformProviderServiceTechnology
Ascension Ventures is a strategic healthcare venture fund with more than $800 million in capital under management. Our limited partners are some of the most respected, values-driven nonprofit healthcare systems in the US.
News
115
Portfolio
83
Mentions
44
Employees: 1-10
Investment Stage: Series B; Series C; Series D; Series G

Portfolio 83

DateNameWebsiteTotal RaisedLocation
16.06.2026Rejonirejoni.com$50MUnited Sta...
11.11.2025Nextsensenextsense.com$16MUnited Sta...
31.05.2023Strive Hea...strivehealth.com$856MUnited Sta...
27.04.2023Tembotembomoney.com$407.49MUnited Kin...
04.08.2022Mindpath H...mindpath.com-United Sta...
26.07.2022Elation He...elationhealth.com$105MUnited Sta...
03.05.2022NEXTSENSE ...nextsense-worldwide.com-Austria, S...
12.04.2022RefleXion ...reflexion.com$581.6MUnited Sta...
08.04.2022Help At Ho...helpathome.com--
26.01.2022Cala Healt...calahealth.com$195MUnited Sta...
Show more

News 115

DateTitleDescription
14.04.2022This Startup Wants to Get in Your Ears and Watch Your Brain-
22.01.2022Vori Health Transforms Back And Joint Pain Treatment-
18.10.2021Recovery Centers of America (RCA) Partners with Owl to Deliver Highly Optimized Clinical Treatment for Patients with Substance Use Disorders-
11.08.2021Alcon to Acquire Ivantis, Inc. and its Hydrus Microstent for Surgical Glaucoma, Strengthening Global Ophthalmology Portfolio-
11.08.2021PursueCare Partners With Owl to Improve Behavioral Health Outcomes for Patients with Substance Use Disorders-
29.07.2021Bardy Diagnostics Carnation Ambulatory Monitor Patch decreases both time to diagnosis and readmissions in Emergency Department patients with possible arrhythmia concerns in Clinical Study from Overlak...-
20.07.2021Value-Based Payment Edges into Employer Programs-
19.07.2021Post-COVID value-based platforms are ready to scale-
17.06.2021Owl Launches New Brand and Adds Industry Leaders to Executive Team-
12.05.2021CSA Medical Announces Completion of Enrollment in Mechanism of Action Study utilizing the RejuvenAir® System for COPD Patients with Chronic Bronchitis-
Show more

Mentions in press and media 44

DateTitleDescription
18.06.2026Rejoni Secures $25M for Uterine Health Innovation, Juveena System Nears LaunchRejoni, a leading women's health company, secured $25 million. This substantial financing fuels the advanced development and market introduction of its Juveena Hydrogel System. Juveena aims to revolutionize uterine healing. It targets the r...
16.06.2026Rejoni Secures $25 Million To Advance Juveena Hydrogel System Toward FDA Approval And Commercial LaunchRejoni, a clinical-stage women’s health company focused on biomaterial therapies, announced the closing of a $25 million financing round to support the development and commercialization of the Juveena Hydrogel System. The financing included...
16.06.2026Rejoni Raises $25M in FundingRejoni, Inc., a Bedford, MA-based clinical-stage company which specializes in uterine health, raised $25M in funding. Backers included Clavyst Bio, Amed Ventures, Ascension Ventures, Catalyst Health Ventures, Delos Capital, FemHealth Ventur...
11.11.2025NextSense Raises $16M in Series A FundingNextSense, a Mountain View, CA-based wearable EEG technology company, closed a $16m Series A funding round. The round was led by Ascension Ventures, with participation from investors including Satori Neuro and Corundrum Neuroscience Fund (C...
11.11.2025NextSense: $16 Million Series A Raised For Advancing Launch Of Clinically Accurate EEG SmartbudsNextSense (see Pulse 2.0 profile here), a company developing wearable EEG technology for consumer wellness, announced the close of a $16 million Series A funding round led by Ascension Ventures. Additional investors in the oversubscribed ro...
10.12.2024Cala Health's $50 Million Surge: A New Dawn for Tremor TherapyCala Health is making waves. The California-based company has just secured $50 million in a growth funding round. This isn't just a financial boost; it's a lifeline for those grappling with essential tremor. Cala Health specializes in bioel...
09.12.2024Cala Health raises $50M to expand wearable tremor therapyPhoto: Mareen Fischinger, Photographer/Getty Images Calif.-based Cala Health, the maker of wearable neuromodulation therapy, announced it completed the initial closing of an oversubscribed $50 million growth round. Vertex Growth Fund and Ne...
09.12.2024Cala Health: Bioelectronic Medicine Leader Raises $50 Million (Growth Round)Cala Health – a non-invasive bioelectronic medicine leader – announced it has raised the initial closing of an oversubscribed $50 million growth round, co-led by Vertex Growth Fund and Nexus NeuroTech Ventures. And all existing Cala investo...
09.12.2024Cala Health Raises $50M for Wearable Tremor TreatmentWhat You Should Know: – Cala Health, the non-invasive bioelectronic medicine leader, today announced it has raised a $50 million growth round, co-led by Vertex Growth Fund and Nexus NeuroTech Ventures. – All existing Cala investors particip...
09.12.2024Cala Health Closes $50M FinancingCala Health, a San Mateo, CA-based non-invasive bioelectronic medicine company, raised $50M in funding. The round was led by Vertex Growth Fund and Nexus NeuroTech Ventures. Existing investors participated in the round, including Action Pot...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In